Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion type Assertion NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_head.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion description "[The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion evidence source_evidence_literature NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion SIO_000772 18779850 NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion wasDerivedFrom befree-2016 NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.
- NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_assertion wasGeneratedBy ECO_0000203 NP692080.RAGm54tZjKdrgO9yl8IoXH58vdJwlmD5k_BrYjBCFqtjU130_provenance.